Activity of Bruton's tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia: a mechanistic study using patient-derived blast cells
Titel:
Activity of Bruton's tyrosine-kinase inhibitor ibrutinib in patients with CD117-positive acute myeloid leukaemia: a mechanistic study using patient-derived blast cells
Auteur:
Rushworth, Stuart A Pillinger, Genevra Abdul-Aziz, Amina Piddock, Rachel Shafat, Manar S Murray, Megan Y Zaitseva, Lyubov Lawes, Matthew J MacEwan, David J Bowles, Kristian M